💡 Want to see how this modality is expanding across modern #radonc? 👉 bit.ly/4eftxRv #radiotherapy #CongressReport
💡 Want to see how this modality is expanding across modern #radonc? 👉 bit.ly/4eftxRv #radiotherapy #CongressReport
👉 https://bit.ly/3TWrYBt
#RadOnc #CancerResearch #CongressReport #RadiationOncology #radiotherapy #Radiobiology
👉 https://bit.ly/3TWrYBt
#RadOnc #CancerResearch #CongressReport #RadiationOncology #radiotherapy #Radiobiology
The ESTRO breast focus group just released their #ESTRO26 congress highlights: nodal irradiation, 5-fraction schedules, #SBRT, #ProtonTherapy, #brachytherapy & more.
👉 https://bit.ly/4p95AjC
#Radonc #CongressReport #cancertreatment #cancerresearch
The ESTRO breast focus group just released their #ESTRO26 congress highlights: nodal irradiation, 5-fraction schedules, #SBRT, #ProtonTherapy, #brachytherapy & more.
👉 https://bit.ly/4p95AjC
#Radonc #CongressReport #cancertreatment #cancerresearch
👉 https://bit.ly/4eIEvAp
#Radonc #GICancer #radiotherapy #CongressReport #CancerResearch #AdaptiveRadiotherapy #SBRT
👉 https://bit.ly/4eIEvAp
#Radonc #GICancer #radiotherapy #CongressReport #CancerResearch #AdaptiveRadiotherapy #SBRT
👉 bit.ly/3RWsqi9 #CongressReport #radonc
👉 bit.ly/3RWsqi9 #CongressReport #radonc
Explore the key highlights and insights from the congress in Prague, which brought together the global PID community to discuss diagnosis and clinical care.
👉 Read the report: l1nq.com/t1fyacf
#IPIC2025 #IPOPI #CongressReport See less
Explore the key highlights and insights from the congress in Prague, which brought together the global PID community to discuss diagnosis and clinical care.
👉 Read the report: l1nq.com/t1fyacf
#IPIC2025 #IPOPI #CongressReport See less
10-yr SiFEBI trial results show single-fraction #brachytherapy is safe & effective for elderly patients with low-risk #breastcancer.
✅ 5% local recurrence
✅ 0 cancer-related deaths
👉 https://bit.ly/4f66sB2
#RadOnc #CongressReport #radiotherapy
10-yr SiFEBI trial results show single-fraction #brachytherapy is safe & effective for elderly patients with low-risk #breastcancer.
✅ 5% local recurrence
✅ 0 cancer-related deaths
👉 https://bit.ly/4f66sB2
#RadOnc #CongressReport #radiotherapy